Horizon Therapeutics Public Limited Company (HZNP)
Price:
116.30 USD
( - 0 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.
NEWS
Amgen: MariTide's Progress, Reassessment Of The Horizon Acquisition
seekingalpha.com
2025-09-25 06:10:55Amgen has not been a great performer in the last two years. Investors became and remain skeptical of MariTide's prospects in obesity, type 2 diabetes, and other related indications. I continue to see MariTide's monthly dosing as a strong selling point and expect that addition of dose escalation to phase 3 trial design will improve its tolerability.
Amgen quarterly profit rises 15% as Horizon deal boosts results
reuters.com
2024-02-06 16:05:15Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.
Cramer names biopharma companies to watch as industry mergers start to pile up
cnbc.com
2024-01-05 19:02:09CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
5 Biotech Acquisition Targets To Accumulate In 2024
seekingalpha.com
2023-12-21 13:05:16Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provide a safety net in uncertain economic conditions.
Amgen: Horizon's Pipeline May Be Too Expensive
seekingalpha.com
2023-10-13 14:00:00We believe that AMGN has overpaid for HZNP's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. The growing debt may also pose headwinds to its profitability and subsequently, dividend growth and balance sheet deleveraging. Then again, it appears that Mr. Market is still convinced about AMGN' profitable growth ahead, as demonstrated by the stock's immense bullish support.
Amgen completes $27.8 bln Horizon deal
reuters.com
2023-10-06 09:18:29Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions.
Horizon Therapeutics (HZNP) Up 10.4% Since Last Earnings Report: Can It Continue?
zacks.com
2023-09-07 12:47:00Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
3 Growth Stocks to Buy in September
marketbeat.com
2023-09-06 10:56:12We're now into September, and that means many investors wonder if the September effect will be in place. This speaks to the historical trend of stocks underperforming in September compared to other months.
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
cnbc.com
2023-09-05 12:56:42Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
businesswire.com
2023-09-05 09:05:00DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement.
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
foxbusiness.com
2023-09-01 14:11:14The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
FTC clears Amgen's $28 billion acquisition of Horizon Therapeutics
invezz.com
2023-09-01 11:59:09Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceutical company.
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
forbes.com
2023-09-01 10:53:09The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.
Amgen, Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger
barrons.com
2023-09-01 10:11:00The Federal Trade Commission makes provision that prohibits “bundling” discounts for some medications.
Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage
investors.com
2023-09-01 09:28:38Amgen stock jumped Friday after the company confirmed the FTC officially cleared its $28 billion acquisition of Horizon Therapeutics.
FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics
marketwatch.com
2023-09-01 09:20:00The Federal Trade Commission reached a deal with Amgen Inc. AMGN, -0.60% to approve its $27.8 billion acquisition of Horizon Therapeutics plc, HZNP, -0.07% the agency announced Friday.
No data to display
Amgen: MariTide's Progress, Reassessment Of The Horizon Acquisition
seekingalpha.com
2025-09-25 06:10:55Amgen has not been a great performer in the last two years. Investors became and remain skeptical of MariTide's prospects in obesity, type 2 diabetes, and other related indications. I continue to see MariTide's monthly dosing as a strong selling point and expect that addition of dose escalation to phase 3 trial design will improve its tolerability.
Amgen quarterly profit rises 15% as Horizon deal boosts results
reuters.com
2024-02-06 16:05:15Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.
Cramer names biopharma companies to watch as industry mergers start to pile up
cnbc.com
2024-01-05 19:02:09CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
5 Biotech Acquisition Targets To Accumulate In 2024
seekingalpha.com
2023-12-21 13:05:16Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provide a safety net in uncertain economic conditions.
Amgen: Horizon's Pipeline May Be Too Expensive
seekingalpha.com
2023-10-13 14:00:00We believe that AMGN has overpaid for HZNP's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. The growing debt may also pose headwinds to its profitability and subsequently, dividend growth and balance sheet deleveraging. Then again, it appears that Mr. Market is still convinced about AMGN' profitable growth ahead, as demonstrated by the stock's immense bullish support.
Amgen completes $27.8 bln Horizon deal
reuters.com
2023-10-06 09:18:29Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions.
Horizon Therapeutics (HZNP) Up 10.4% Since Last Earnings Report: Can It Continue?
zacks.com
2023-09-07 12:47:00Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock?
3 Growth Stocks to Buy in September
marketbeat.com
2023-09-06 10:56:12We're now into September, and that means many investors wonder if the September effect will be in place. This speaks to the historical trend of stocks underperforming in September compared to other months.
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
cnbc.com
2023-09-05 12:56:42Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
businesswire.com
2023-09-05 09:05:00DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement.
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
foxbusiness.com
2023-09-01 14:11:14The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
FTC clears Amgen's $28 billion acquisition of Horizon Therapeutics
invezz.com
2023-09-01 11:59:09Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceutical company.
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
forbes.com
2023-09-01 10:53:09The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.
Amgen, Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger
barrons.com
2023-09-01 10:11:00The Federal Trade Commission makes provision that prohibits “bundling” discounts for some medications.
Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage
investors.com
2023-09-01 09:28:38Amgen stock jumped Friday after the company confirmed the FTC officially cleared its $28 billion acquisition of Horizon Therapeutics.
FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics
marketwatch.com
2023-09-01 09:20:00The Federal Trade Commission reached a deal with Amgen Inc. AMGN, -0.60% to approve its $27.8 billion acquisition of Horizon Therapeutics plc, HZNP, -0.07% the agency announced Friday.